1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2024
2. Prostate specific antigen and biopsy contamination in the Göteborg-1 randomized, population-based, prostate cancer screening trial;Stinesen Kollberg;J Urol,2022
3. Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial;Nam;BMJ Open,2022
4. Multiparametric magnetic resonance imaging in prostate cancer screening at the age of 45 years: results from the first screening round of the PROBASE trial;Boschheidgen;Eur Urol,2024
5. Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy;Choi;Prostate Int,2023